Revium Rx (RVRC) Common Equity (2024 - 2026)
Revium Rx (RVRC) posted Common Equity of $6.9 million for Q4 2025, down 65.08% sequentially from $19.7 million in Q4 2024, and down 65.08% YoY from $19.7 million in Q4 2024.
Revium Rx (RVRC) Common Equity (2024 - 2026) Analysis & Trends
Revium Rx has reported Common Equity for 2 years, with the latest figure at $6.9 million in Q4 2025.
- Quarterly Common Equity fell 65.08% year-over-year to $6.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.9 million (down 65.08% YoY) and the FY2025 annual result came in at $6.9 million, down 65.08% from the prior year.
- Common Equity declined to $6.9 million in Q4 2025 per RVRC's latest filing, from $19.7 million in the prior quarter.
- Over five years, Common Equity peaked at $19.7 million in Q4 2024 and troughed at $6.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | 7.30 Bn |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | 2.05 Bn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | 2.05 Bn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | 825.55 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | 344.33 Mn |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | 3.61 Bn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | 3.99 Bn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | 916.07 Mn |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | 279.73 Mn |
| 10 | Revium Rx | 101.42 Mn | 99.91 Mn | - | 5.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.52 Mn |
| Dec 31, 2025 | 6.88 Mn |
| Dec 31, 2024 | 19.71 Mn |